BioDelivery Sciences International, Inc. (BDSI) News



BioDelivery Sciences International, Inc. (BDSI)

Today's Latest Price: $4.14 USD

0.07 (-1.66%)

Updated Jan 22 4:00pm

Add BDSI to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 484 in Biotech

See all "A" rated Strong Buy stocks

StocksNews Articles for BDSI

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest BDSI News From Around the Web

Below are the latest news stories about Biodelivery Sciences International Inc that investors may wish to consider to help them evaluate BDSI as an investment opportunity.

BioDelivery Sciences to Present Three Scientific Posters Comparing BELBUCA® to Oxycodone at the 2021 North American Neuromodulation Society (NANS) Meeting

Oral Presentation of Data from Phase I Safety Study & Secondary Respiratory Outcomes Comparing BELBUCA® to Oxycodone on January 16 from 1:10pm – 2:10pm CTRALEIGH, N.C., Jan. 15, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with chronic conditions, will present three scientific posters regarding BELBUCA® (buprenorphine buccal film), CIII at the 2021 North American Neuromodulation Society Meeting (NANS) taking place virtually January 15-16, 2021.“We are pleased to be presenting this data at NANS 2021 and sharing this information with the scientific community,” said Thomas Smith, M.D., Chief Medical Officer of BDSI.Data from a placebo-controlled study compared safety outcom...

Yahoo | January 15, 2021

Musculoskeletal Pains Market - Insights On Scope 2025 | Zogenix, Inc., Dainippon Sumitomo Pharma Co., Ltd., BioDelivery Sciences International, Inc.

Global Musculoskeletal Pains Market: Snapshot Musculoskeletal pain is pain that affects bones, muscles, or the various types of connective tissues that hold the two together, such as tendons and ligaments. This type of pain can occur due to overuse or repetitive

OpenPR | January 6, 2021

Are Robust Financials Driving The Recent Rally In BioDelivery Sciences International, Inc.'s (NASDAQ:BDSI) Stock?

BioDelivery Sciences International's (NASDAQ:BDSI) stock is up by a considerable 15% over the past three months. Given...

Yahoo | December 22, 2020

BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Insider James Vollins Sells 20,320 Shares

BioDelivery Sciences International, Inc. (NASDAQ:BDSI) insider James Vollins sold 20,320 shares of the firm’s stock in a transaction that occurred on Monday, December 14th. The shares were sold at an average price of $4.46, for a total transaction of $90,627.20. Following the transaction, the insider now owns 20,320 shares in the company, valued at approximately […]

Watchlist News | December 19, 2020

Top Biotech Stocks for Q1 2021

The biotechnology industry includes companies that develop drugs and diagnostic compounds for the treatment of diseases and medical conditions. These products must go through a rigorous, costly, and time-consuming testing process before potentially obtaining approval from the U.

Yahoo | December 9, 2020

BioDelivery (BDSI) Up 9.5% Since Last Earnings Report: Can It Continue?

BioDelivery (BDSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 5, 2020

BioDelivery Sciences to Participate in the Piper Sandler 32nd Annual Healthcare Conference

RALEIGH, N.C., Nov. 20, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical…

GlobeNewswire | November 20, 2020

BioDelivery Sciences to Present Virtually and Host 1x1 Investor Meetings at the Annual Southwest IDEAS Investor Conference on November 18

RALEIGH, N.C., Nov. 11, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that Jeffrey Bailey, Chief Executive Officer, and Terry Coelho, Chief Financial Officer, will participate in the virtual Southwest IDEAS Investor Conference on November 18, 2020. BDSI’s presentation will be webcasted and is scheduled to be available at 7:00 am CST on November 18. The presentation can be accessed through the Southwest IDEAS conference portal for registered participants, in the investor relations section of the Company's website: www.bdsi.com, and on the IDEAS conference website: www.IDEASconferences.com. About IDEAS Investor Co...

Yahoo | November 11, 2020

BioDelivery Sciences International, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year

It's been a good week for BioDelivery Sciences International, Inc. (NASDAQ:BDSI) shareholders, because the company has...

Yahoo | November 7, 2020

Is BioDelivery Sciences International (NASDAQ:BDSI) Using Too Much Debt?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...

Yahoo | November 6, 2020



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6191 seconds.